U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Bought by Deutsche Bank AG

Deutsche Bank AG grew its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 49.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,176 shares of the company's stock after buying an additional 4,350 shares during the period. Deutsche Bank AG owned 0.09% of U.S. Physical Therapy worth $1,169,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. CBIZ Investment Advisory Services LLC raised its holdings in shares of U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after buying an additional 122 shares in the last quarter. Venturi Wealth Management LLC boosted its position in shares of U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after purchasing an additional 704 shares in the last quarter. Pacer Advisors Inc. bought a new stake in shares of U.S. Physical Therapy during the 4th quarter valued at about $113,000. Aquatic Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 18.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after purchasing an additional 198 shares in the last quarter. Finally, Mutual of America Capital Management LLC bought a new position in U.S. Physical Therapy in the fourth quarter worth approximately $203,000.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock traded up $0.10 during trading on Friday, reaching $75.70. 6,922 shares of the stock traded hands, compared to its average volume of 111,265. The company has a market capitalization of $1.15 billion, a price-to-earnings ratio of 80.53, a P/E/G ratio of 3.54 and a beta of 1.44. The business has a fifty day simple moving average of $71.99 and a two-hundred day simple moving average of $82.83. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $102.89.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. During the same quarter in the previous year, the business earned $0.51 earnings per share. The company's revenue for the quarter was up 18.0% compared to the same quarter last year. Sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.38%. The ex-dividend date of this dividend is Friday, May 23rd. U.S. Physical Therapy's payout ratio is 82.57%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Barrington Research dropped their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. JMP Securities reaffirmed a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. decreased their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Wednesday, March 19th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares of the company's stock, valued at $588,564.48. This trade represents a 19.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.00% of the company's stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.